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is over 9, at 9.26, reﬂecting the huge improvement in its visibility.
The Journal of Hepatology is undoubtedly among the top interna-
tional journals in the ﬁeld of Hepatology. We are willing to
receive and publish original papers from all over the world. Our
aim is to select the best papers, whatever their country of origin.
This achievement is clearly shown by the origin of the submit-
ted original manuscripts: 42%, 37%, 14% and 7% are from Asia,
Europe, USA and English speaking countries (Canada and
Australia) and others, respectively. 23%, 54%, 20% and 3% of
the published manuscripts are from Asia, Europe, USA and
English speaking countries (Canada and Australia) and others,
respectively.
The Journal of Hepatology is, with the annual International
Liver Congress™, the ﬂag of EASL.
In addition, our goal is to have a balanced representation of
clinical and basic research. The main criteria for our choices are
excellence, originality, interest and quality. Our editorial team
aims at developing the relationship between basic science and
clinical application, and at giving our readers the most updated
information on the scientiﬁc progress in Hepatology. This feature
is particularly highlighted in our invited reviews and within the 2
sections Clinical Applications of Basic Science and Snapshots in
Hepatology. We have paid particular attention to the quality of
our invited reviews and I wish to thank the authors who provided
updated and top-notch reviews either in clinical or basic science
ﬁelds. Moreover, with the regular publications of the EASL ClinicalJournal of Hepatology 20
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E-mail address: didier.samuel@pbr.aphp.fr.Practice Guidelines, we provide our readers with a large overview
in Hepatology, from basic aspects to clinical application and ther-
apeutic guidelines.
The Journal is also adapting to the new media, with the devel-
opment, over the last year, of a new website, with bimonthly
updated web content, and monthly videocasts. The new EASL
membership will offer the possibility to get either the e-version
of the Journal alone or both the printed and e-versions.
We are currently developing an iPad and tablet version of the
Journal, which should be ready in 2013.
Along the same lines, we will continue improving the layout
of the Journal, and the quality of the papers, tables and ﬁgures
published.
I wish also to sincerely thank the team of co-Editors, associate
Editors and special section Editors for the huge and high-quality
work done in the last years.
I wish to thank the editorial team in Geneva for their support,
their highly professional input and their help in the constant
improvement of the Journal.
I also thank Mark Thursz, EASL Secretary General, and the gov-
erning board of EASL for the continuous support to our team.
I do not forget that the quality of the Journal depends on the
quality of the submitted papers and I hope to receive from
authors their best articles.
Finally, I thank our readers and sincerely hope you will con-
tinue to enjoy the Journal of Hepatology in 2013.
We wish you all an Excellent Year 2013!13 vol. 58 j 3
